Platelet-activating factor (PAF)-like oxidized phospholipids: Relevance to atherosclerosis

被引:25
|
作者
Tokumura, A [1 ]
Sumida, T [1 ]
Toujima, M [1 ]
Kogure, K [1 ]
Fukuzawa, K [1 ]
机构
[1] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 7708505, Japan
关键词
platelet-activating factor; oxidized phosphatidylcholine; oxidized low density lipoprotein; atherosclerosis;
D O I
10.1002/biof.5520130106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid peroxidation is involved in the pathogenesis of chronic diseases including atherosclerosis. Oxidized lipoprotein has diverse biological activities and is believed to initiate atheroma formation and maturate fatty plaque. The active components of oxidized lipoproteins still remain to be clarified, but a likely candidate is the phosphatidylcholine (PC) having an sn-2-short-chain acyl group with a methyl, hydroxyl, aldehydic or carboxylic terminal. These unique PCs, formed by oxidative fragmentation of the polyunsaturated acyl group of the parent PC in liposomes, low density lipoproteins and blood plasma, induce platelet aggregation through the activation of the receptor for platelet-activating factor (PAF), due to their resemblance in structure with PAF. We have found that PAF-like lipids regulate DNA synthesis acid production of nitric oxide independently of the activation of the PAF receptor in vascular smooth muscle cells. Regulation of vascular cell function through two distinct signaling pathways mediated by PAF-like lipids provides new insight into the mechanism of induction of atherosclerosis.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [41] The Induction of an Angiogenic Response in Corneal Myofibroblasts by Platelet-Activating Factor (PAF)
    He, Jiucheng
    Eastlack, Jason P.
    Bazan, Haydee E. P.
    CURRENT EYE RESEARCH, 2010, 35 (12) : 1063 - 1071
  • [42] The actions,detection and synthesis of platelet-activating factor (PAF) in mammalian pregnancy
    刘玉堂
    隋淑芹
    孙中武
    毕冰
    许翠清
    Journal of Forestry Research, 1998, (04) : 283 - 287
  • [43] ROLE OF PLATELET-ACTIVATING FACTOR (PAF) IN OVOIMPLANTATION AND DECIDUALIZATION PROCESS IN THE RAT
    ACKER, GM
    BRAQUET, P
    MENCIAHUERTA, JM
    PROSTAGLANDINS, 1988, 35 (05): : 817 - 817
  • [44] PLATELET-ACTIVATING FACTOR (PAF-ACETHER), AN ACTIVATOR OF NEUTROPHIL FUNCTIONS
    JOUVINMARCHE, E
    POITEVIN, B
    BENVENISTE, J
    AGENTS AND ACTIONS, 1982, 12 (5-6): : 716 - 720
  • [45] Regulation of platelet activating factor acetylhydrolase expression by oxidized phospholipids
    Griffiths, Rachael
    Leitinger, Norbert
    Barbour, Suzanne E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E88 - E88
  • [46] The actions, detection and synthesis of platelet-activating factor (PAF) in mammalian pregnancy
    Liu Yutang
    Sui Shuqin
    Sun Zhongwu
    Bi Bing
    Xu Cuiqing
    Journal of Forestry Research, 1998, 9 (4) : 283 - 287
  • [47] PLATELET-ACTIVATING FACTOR (PAF) AND NEONATAL HYPOXIC PULMONARY VASOCONSTRICTION (HPV)
    STAMBOULY, J
    BRADLEY, L
    GOLDSTEIN, R
    PEDIATRIC RESEARCH, 1989, 25 (04) : A245 - A245
  • [48] THE PRESENCE OF PLATELET-ACTIVATING FACTOR (PAF) IN NORMAL HUMAN-SALIVA
    COX, CP
    JORGENSEN, R
    WARDLOW, ML
    FARR, RS
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 1021 - 1021
  • [49] EFFECT OF PLATELET-ACTIVATING FACTOR (PAF) AND SYNTHETIC ANALOGS ON FIBRINOLYSIS IN RATS
    HOFMANN, B
    MEISGEIER, U
    GREINER, J
    KERTSCHER, HP
    OSTERMANN, G
    FIBRINOLYSIS, 1990, 4 (04) : 247 - 252
  • [50] Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis
    Abeck, D
    Andersson, T
    Grosshans, E
    Jablonska, S
    Kragballe, K
    Vahlquist, A
    Schmidt, T
    Dupuy, P
    Ring, J
    ACTA DERMATO-VENEREOLOGICA, 1997, 77 (06) : 449 - 451